Look for:

Our offer for

WUXI BIOLOGICS (CAYMAN) INC.


ISIN:
KYG970081173
WKN:
-
2024/10/18 19:30:25
Price
1.9572 EUR
Difference 10.22% (0.18)

General attributes

ISINKYG970081173
Symbol2269
ExchangeDuesseldorf
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)8,144 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)-
Ask (Ask size)-
Open1.909 EUR
High1.9572 EUR
Low1.909 EUR
Close (prev. day)1.7758 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades7
Last size0

Futures and Options

Related Futures-
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2024/09/27 en Global Equity Ratings PDF Download
2024/09/11 en Global Equity Ratings PDF Download
2024/09/05 en Global Equity Ratings PDF Download
2024/08/12 en Global Equity Ratings PDF Download
2024/07/24 en Global Equity Ratings PDF Download


2024/10/18 19:30:25
Price
1.9572 EUR
Difference 10.22% (0.18)

General attributes

ISINKYG970081173
Symbol2269
ExchangeDuesseldorf
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)8,144 EUR
BenchmarkMSCI WORLD INDEX (STRD, UHD)

Market data

Bid (Bid size)-
Ask (Ask size)-
Open1.909 EUR
High1.9572 EUR
Low1.909 EUR
Close (prev. day)1.7758 EUR
VWAP-
Volume (pcs)0
Trading volume0.00
Number of trades7
Last size0

Performance and Risk

6m1Y3Y
Perf (%)+24.71%-65.42%-84.34%
Perf (abs.)+0.39-3.70-10.54
Beta1.110.870.72
Volatility75.1481.6073.64
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)1.8705 EUR (0)
Ø price 30 days | Ø volume 30 days (pcs.)1.7439 EUR (223)
Ø price 100 days | Ø volume 100 days (pcs.)1.4323 EUR (397)
Ø price 250 days | Ø volume 250 days (pcs.)2.2756 EUR (182)
YTD High | date3.5420 EUR (2024/01/16)
YTD Low | date1.1500 EUR (2024/08/22)
52 Weeks High | date6.0900 EUR (2023/11/08)
52 Weeks Low | date1.1500 EUR (2024/08/22)

All listings for WUXI BIOLOGICS (CAYMAN) INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/10/1822:262.003 EUR0.0317
Stuttgart2024/10/1815:501.969 EUR0.015
Munich2024/10/1817:162.0385 EUR0.012
Hong Kong Stock Exchange2024/10/1810:0816.50 HKD--
Frankfurt2024/10/1808:121.9138 EUR0.002
FINRA other OTC Issues2024/10/0217:462.50 USD0.014
Duesseldorf2024/10/1819:301.9572 EUR0.007
Berlin2024/10/1818:462.0015 EUR0.007

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=143050&ID_TYPE_IMAGE_LOGO=2

Contact Details

WUXI BIOLOGICS (CAYMAN) INC.
- -
- - - -
Telefon: -
Fax: -
E-mail: -

Company Profile

-

Members of Management Board

Zhisheng (Chris) Chen, Ph.D.Chairman of Managing Board
Christine Lu-WongMember of Executive Committee
Jijie Gu, Ph.D.Member of Executive Committee
Weichang Zhou, Ph.D.Member of Executive Committee

Board of directors

Ge LiChairman of Supervisory Board
Jue ChenMember of Supervisory Board
Weichang ZhouMember of Supervisory Board
Yi Bing WuMember of Supervisory Board
Jackson TaiMember of Supervisory Board
Kenneth HitchnerMember of Supervisory Board
William KellerMember of Supervisory Board
Yan Ling CaoMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer